Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
- Type
- Retraction
- Notice date
- 6/14/2022 0:00
- Journal
- Oncology Reports
- Publisher
- Spandidos
- Notice DOI
- 10.3892/or.2022.8297
- Original paper DOI
- 10.3892/or.2015.3730